ABVC BioPharma Inc (ABVC)
1.06
-0.02
(-1.85%)
USD |
NASDAQ |
May 07, 16:00
1.07
+0.01
(+0.94%)
After-Hours: 06:19
ABVC BioPharma Cash from Operations (Quarterly): -0.4795M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.4795M |
| September 30, 2023 | -1.359M |
| June 30, 2023 | -0.8998M |
| March 31, 2023 | -1.498M |
| December 31, 2022 | -0.4611M |
| September 30, 2022 | -0.5137M |
| June 30, 2022 | -3.429M |
| March 31, 2022 | -2.994M |
| December 31, 2021 | -2.525M |
| September 30, 2021 | -2.216M |
| June 30, 2021 | -1.444M |
| March 31, 2021 | -1.413M |
| December 31, 2020 | -2.188M |
| September 30, 2020 | -0.3288M |
| June 30, 2020 | -1.416M |
| March 31, 2020 | -0.6309M |
| December 31, 2019 | -1.496M |
| September 30, 2019 | -0.2422M |
| June 30, 2019 | -0.797M |
| March 31, 2019 | -0.5995M |
| December 31, 2018 | 0.5381M |
| September 30, 2018 | -0.2103M |
| June 30, 2018 | -0.4325M |
| March 31, 2018 | -0.5255M |
| September 30, 2017 | -0.3232M |
| Date | Value |
|---|---|
| June 30, 2017 | -0.1884M |
| March 31, 2017 | -0.8622M |
| December 31, 2016 | -0.2249M |
| September 30, 2016 | -0.2114M |
| June 30, 2016 | -2.834M |
| March 31, 2016 | 0.4454M |
| December 31, 2015 | -0.8743M |
| September 30, 2015 | 0.0011M |
| June 30, 2015 | 0.0023M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.0012M |
| June 30, 2014 | -0.00 |
| March 31, 2014 | -0.00 |
| December 31, 2013 | -0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | -0.0002M |
| March 31, 2013 | -0.0012M |
| December 31, 2012 | -0.0364M |
| September 30, 2012 | -0.0942M |
| June 30, 2012 | -0.2386M |
| March 31, 2012 | -0.2157M |
| December 31, 2011 | -0.3666M |
| September 30, 2011 | -0.3006M |
| June 30, 2011 | -0.3397M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-3.429M
Minimum
Jun 2022
-0.2422M
Maximum
Sep 2019
-1.386M
Average
-1.413M
Median
Mar 2021
Cash from Operations (Quarterly) Benchmarks
| NeuBase Therapeutics Inc | -2.003M |
| Sutro Biopharma Inc | 14.07M |
| Reviva Pharmaceuticals Holdings Inc | -8.876M |
| Flora Growth Corp | -1.131M |
| Journey Medical Corp | -16.52M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.1542M |
| Cash from Financing (Quarterly) | 0.0874M |
| Free Cash Flow | -4.257M |
| Free Cash Flow Per Share (Quarterly) | -0.0606 |
| Free Cash Flow to Equity (Quarterly) | 0.5583M |
| Free Cash Flow to Firm (Quarterly) | 0.6456M |
| Free Cash Flow Yield | -86.44% |